Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study
- PMID: 22007043
- PMCID: PMC3726800
- DOI: 10.7326/0003-4819-155-8-201110180-00005
Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study
Abstract
Background: Few studies have examined the comparative effectiveness of digital versus film-screen mammography in U.S. community practice.
Objective: To determine whether the interpretive performance of digital and film-screen mammography differs.
Design: Prospective cohort study.
Setting: Mammography facilities in the Breast Cancer Surveillance Consortium.
Participants: 329,261 women aged 40 to 79 years underwent 869 286 mammograms (231 034 digital; 638 252 film-screen).
Measurements: Invasive cancer or ductal carcinoma in situ diagnosed within 12 months of a digital or film-screen examination and calculation of mammography sensitivity, specificity, cancer detection rates, and tumor outcomes.
Results: Overall, cancer detection rates and tumor characteristics were similar for digital and film-screen mammography, but the sensitivity and specificity of each modality varied by age, tumor characteristics, breast density, and menopausal status. Compared with film-screen mammography, the sensitivity of digital mammography was significantly higher for women aged 60 to 69 years (89.9% vs. 83.0%; P = 0.014) and those with estrogen receptor-negative cancer (78.5% vs. 65.8%; P = 0.016); borderline significantly higher for women aged 40 to 49 years (82.4% vs. 75.6%; P = 0.071), those with extremely dense breasts (83.6% vs. 68.1%; P = 0.051), and pre- or perimenopausal women (87.1% vs. 81.7%; P = 0.057); and borderline significantly lower for women aged 50 to 59 years (80.5% vs. 85.1%; P = 0.097). The specificity of digital and film-screen mammography was similar by decade of age, except for women aged 40 to 49 years (88.0% vs. 89.7%; P < 0.001).
Limitation: Statistical power for subgroup analyses was limited.
Conclusion: Overall, cancer detection with digital or film-screen mammography is similar in U.S. women aged 50 to 79 years undergoing screening mammography. Women aged 40 to 49 years are more likely to have extremely dense breasts and estrogen receptor-negative tumors; if they are offered mammography screening, they may choose to undergo digital mammography to optimize cancer detection.
Primary funding source: National Cancer Institute.
Conflict of interest statement
Comment in
-
Comparative effectiveness of digital versus film-screen mammography.Ann Intern Med. 2012 Feb 7;156(3):249-50; author reply 251. doi: 10.7326/0003-4819-156-3-201202070-00021. Ann Intern Med. 2012. PMID: 22312149 No abstract available.
-
Comparative effectiveness of digital versus film-screen mammography.Ann Intern Med. 2012 Feb 7;156(3):250; author reply 251. doi: 10.7326/0003-4819-156-3-201202070-00022. Ann Intern Med. 2012. PMID: 22312150 No abstract available.
-
Comparative effectiveness of digital versus film-screen mammography.Ann Intern Med. 2012 Feb 7;156(3):250; author reply 251. doi: 10.7326/0003-4819-156-3-201202070-00023. Ann Intern Med. 2012. PMID: 22312151 No abstract available.
Summary for patients in
-
Summaries for patients: the accuracy of film versus digital screening mammography.Ann Intern Med. 2011 Oct 18;155(8):I30. doi: 10.7326/0003-4819-155-8-201110180-00002. Ann Intern Med. 2011. PMID: 22007060 No abstract available.
Similar articles
-
Diagnostic accuracy of digital versus film mammography: exploratory analysis of selected population subgroups in DMIST.Radiology. 2008 Feb;246(2):376-83. doi: 10.1148/radiol.2461070200. Radiology. 2008. PMID: 18227537 Free PMC article.
-
Comparison of direct digital mammography, computed radiography, and film-screen in the French national breast cancer screening program.AJR Am J Roentgenol. 2014 Jan;202(1):229-36. doi: 10.2214/AJR.12.10419. AJR Am J Roentgenol. 2014. PMID: 24370149
-
Breast Cancer Characteristics Associated With Digital Versus Film-Screen Mammography for Screen-Detected and Interval Cancers.AJR Am J Roentgenol. 2015 Sep;205(3):676-84. doi: 10.2214/AJR.14.13904. AJR Am J Roentgenol. 2015. PMID: 26295657 Free PMC article.
-
Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Service Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Jan. Report No.: 14-05201-EF-3. Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Jan. Report No.: 14-05201-EF-3. PMID: 26866210 Free Books & Documents. Review.
-
Digital Breast Tomosynthesis with Hologic 3D Mammography Selenia Dimensions System for Use in Breast Cancer Screening: A Single Technology Assessment [Internet].Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2017 Sep 4. Report from the Norwegian Institute of Public Health No. 2017-08. Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2017 Sep 4. Report from the Norwegian Institute of Public Health No. 2017-08. PMID: 29553669 Free Books & Documents. Review.
Cited by
-
Tumor-derived EV miRNA signatures surpass total EV miRNA in supplementing mammography for precision breast cancer diagnosis.Theranostics. 2024 Oct 7;14(17):6587-6604. doi: 10.7150/thno.99245. eCollection 2024. Theranostics. 2024. PMID: 39479442 Free PMC article.
-
Knowledge, attitude, and practice towards breast self-examination among women: a web based community study.Front Public Health. 2024 Oct 7;12:1450082. doi: 10.3389/fpubh.2024.1450082. eCollection 2024. Front Public Health. 2024. PMID: 39435407 Free PMC article.
-
Multiview deep learning networks based on automated breast volume scanner images for identifying breast cancer in BI-RADS 4.Front Oncol. 2024 Sep 6;14:1399296. doi: 10.3389/fonc.2024.1399296. eCollection 2024. Front Oncol. 2024. PMID: 39309734 Free PMC article.
-
Consistency Analysis of CTLM Imaging and Mammography in the Diagnosis of Breast Tumor Lesions.J Healthc Eng. 2022 Mar 29;2022:5391636. doi: 10.1155/2022/5391636. eCollection 2022. J Healthc Eng. 2022. PMID: 39290687 Free PMC article.
-
Screening Programs for Breast Cancer: Toward Individualized, Risk-Adapted Strategies of Early Detection.Cancer Treat Res. 2023;188:63-88. doi: 10.1007/978-3-031-33602-7_3. Cancer Treat Res. 2023. PMID: 38175342
References
-
- U.S. Food and Drug Administration. Mammography Quality Standards Act and Program. Accessed at www.fda.gov/Radiation-EmittingProducts/MammographyQualityStandardsActand... on 17 October 2010.
-
- Pisano ED, Gatsonis C, Hendrick E, Yaffe M, Baum JK, Acharyya S, et al. Digital Mammographic Imaging Screening Trial (DMIST) Investigators Group. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med. 2005;353:1773–1783. [PMID: 16169887] - PubMed
-
- Lewin JM, D’Orsi CJ, Hendrick RE, Moss LJ, Isaacs PK, Karellas A, et al. Clinical comparison of full-field digital mammography and screen-film mammography for detection of breast cancer. AJR Am J Roentgenol. 2002;179:671–677. [PMID: 12185042] - PubMed
-
- Skaane P. Studies comparing screen-film mammography and full-field digital mammography in breast cancer screening: updated review. Acta Radiol. 2009;50:3–14. [PMID: 19037825] - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 CA063740/CA/NCI NIH HHS/United States
- U01CA69976/CA/NCI NIH HHS/United States
- U01 CA070040/CA/NCI NIH HHS/United States
- RC2CA148577/CA/NCI NIH HHS/United States
- U01CA70013/CA/NCI NIH HHS/United States
- U01 CA086082/CA/NCI NIH HHS/United States
- U01CA63736/CA/NCI NIH HHS/United States
- U01CA86082/CA/NCI NIH HHS/United States
- R03CA150007/CA/NCI NIH HHS/United States
- U01CA70040/CA/NCI NIH HHS/United States
- U01CA63740/CA/NCI NIH HHS/United States
- U01 CA063731/CA/NCI NIH HHS/United States
- U01 CA086076/CA/NCI NIH HHS/United States
- R03 CA150007/CA/NCI NIH HHS/United States
- RC2 CA148577/CA/NCI NIH HHS/United States
- U01 CA069976/CA/NCI NIH HHS/United States
- U01CA86076/CA/NCI NIH HHS/United States
- U01 CA063736/CA/NCI NIH HHS/United States
- U01 CA070013/CA/NCI NIH HHS/United States
- U01CA63731/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical